Market Value3,285,596,936
Total Holdings66
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PSTX / Poseida Therapeutics, Inc.
IMTX / Immatics N.V.
NUVB / Nuvation Bio Inc.
ALLO / Allogene Therapeutics, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
XNCR / Xencor, Inc.
MORF / Morphic Holding, Inc.
DTIL / Precision BioSciences, Inc.
GERN / Geron Corporation
CMAXW / CareMax Inc - Warrants (08/06/2026)
ACAD / ACADIA Pharmaceuticals Inc.
ALGS / Aligos Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
DSGN / Design Therapeutics, Inc. Call
SRZNW / Surrozen, Inc. - Equity Warrant
KYMR / Kymera Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
PRTA / Prothena Corporation plc
HSAQ / Health Sciences Acquisitions Corp 2
EUCR / Eucrates Biomedical Acquisition Corp
ARYD / ARYA Sciences Acquisition Corp IV
/ VENTYX BIOSCIENCES INC
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
CGEM / Cullinan Therapeutics, Inc.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BLSA / BCLS Acquisition Corp - Class A
HOOK / HOOKIPA Pharma Inc.
NUVL / Nuvalent, Inc.
KNTE / Kinnate Biopharma Inc.
KYG9127T1242 / WARRANTS
JYAC / Jiya Acquisition Corp - Class A
ARGX / argenx SE - Depositary Receipt (Common Stock)
TMPM / Turmeric Acquisition Corp - Class A
AKUS / Akouos Inc
FVAM / 5:01 Acquisition Corp.
OMEG / Omega Alpha SPAC - Class A
FLAC / Frazier Lifesciences Acquisition Corp - Class A
DSGN / Design Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
SURF / Surface Oncology Inc
RETA / Reata Pharmaceuticals Inc - Class A
PRME / Prime Medicine, Inc.
PRAX / Praxis Precision Medicines, Inc.
BCAB / BioAtla, Inc.
AVEO / AVEO Pharmaceuticals Inc
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
KDNY / Chinook Therapeutics Inc
MRTX / Mirati Therapeutics, Inc.
ARVN / Arvinas, Inc.
ABEO / Abeona Therapeutics Inc.
JANX / Janux Therapeutics, Inc.
ZYME / Zymeworks Inc.
VYGR / Voyager Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
BDTX / Black Diamond Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
ACET / Adicet Bio, Inc.
ERAS / Erasca, Inc.
EWTX / Edgewise Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
OVID / Ovid Therapeutics Inc.
GRPH / Graphite Bio, Inc.
ALEC / Alector, Inc.
SELB / Selecta Biosciences Inc
MGNX / MacroGenics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
APLS / Apellis Pharmaceuticals, Inc.
NGM / NGM Biopharmaceuticals, Inc.
RLAY / Relay Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
AVIR / Atea Pharmaceuticals, Inc.
TPST / Tempest Therapeutics, Inc.
KRON / Kronos Bio, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
RVMD / Revolution Medicines, Inc.
DYN / Dyne Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.